Meta-Analysis of the Immunogenicity and Tolerability of Pandemic Influenza A 2009 (H1N1) Vaccines
Article 2011 en
Authors
LM
Lamberto Manzoli
CV
Corrado De Vito
GS
Georgia Salanti
Abstract
1 min read
Several one-dose formulations might be valid for future vaccines, but 2 doses may be needed for children, especially if a low-dose non-adjuvanted vaccine is used. Given that 15 RCTs were sponsored by vaccine manufacturers, future trials sponsored by non-industry agencies and comparing vaccines using different types of adjuvants are needed.
Victoria Hall, Thi H. O. Nguyen, Olivia Smibert, Lilith F. Allen, Sheena G. Sullivan, Annette Fox, Louise Carolan, Adam K. Wheatley, Stephen J. Kent, Brad Gilbertson, Chhay Lim, Ian Barr, Heidi Peck, Paula Fuge-Larsen, Emily Klimevski, G. Surekha Tennakoon, Natalie R Saunders, Trish Joyce, Ashley Whitechurch, Amit Khot, Mary Ann Anderson, Jason A. Trubiano,
Geert V.T. Roozen, Margaretha Prins, Rob van Binnendijk, Gerco den Hartog, Vincent P. Kuiper, Corine Prins, Jacqueline J. Janse, Annelieke C. Kruithof, Mariet C.W. Feltkamp, Marjan Kuijer, Frits R. Rosendaal, Meta Roestenberg, Leo G. Visser, Anna H.E. Roukens
Discussion(0)
No comments yet. Be the first to comment.